James Dewey Hocker, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Regulatory Sequences, Nucleic Acid | 2 | 2021 | 786 | 0.620 |
Why?
|
| Heart | 3 | 2023 | 4387 | 0.340 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 695 | 0.340 |
Why?
|
| Chromatin | 5 | 2023 | 2925 | 0.310 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 1398 | 0.290 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 1983 | 0.250 |
Why?
|
| Transcription Factor AP-1 | 1 | 2023 | 321 | 0.200 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 4515 | 0.200 |
Why?
|
| Immunologic Memory | 2 | 2019 | 1331 | 0.180 |
Why?
|
| Palliative Care | 1 | 2015 | 3595 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2019 | 76 | 0.160 |
Why?
|
| Electronic Health Records | 1 | 2015 | 4678 | 0.150 |
Why?
|
| Adoptive Transfer | 2 | 2019 | 793 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2016 | 2520 | 0.140 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 562 | 0.130 |
Why?
|
| Wisconsin | 1 | 2015 | 121 | 0.130 |
Why?
|
| RNA, Small Untranslated | 1 | 2015 | 78 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2022 | 2910 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1230 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2021 | 877 | 0.110 |
Why?
|
| Antigens, CD19 | 1 | 2016 | 413 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 5793 | 0.110 |
Why?
|
| Transcription Factors | 3 | 2022 | 12073 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2023 | 2974 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2019 | 3779 | 0.100 |
Why?
|
| Myocardium | 1 | 2023 | 4673 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2329 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 1825 | 0.090 |
Why?
|
| Heart Diseases | 1 | 2022 | 2798 | 0.080 |
Why?
|
| Genome, Human | 1 | 2021 | 4407 | 0.080 |
Why?
|
| Cancer Vaccines | 1 | 2015 | 1050 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 1401 | 0.070 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2015 | 1427 | 0.070 |
Why?
|
| Stem Cells | 1 | 2019 | 3526 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 1864 | 0.060 |
Why?
|
| Binding Sites | 2 | 2023 | 6046 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 4706 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2023 | 4068 | 0.050 |
Why?
|
| Cell Differentiation | 4 | 2021 | 11444 | 0.050 |
Why?
|
| Protein Binding | 2 | 2023 | 9309 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5785 | 0.040 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2019 | 67 | 0.040 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2019 | 133 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10057 | 0.040 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2019 | 174 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 1134 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2021 | 1955 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2020 | 0.030 |
Why?
|
| Humans | 10 | 2023 | 755562 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2021 | 2691 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2021 | 1758 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2756 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 1341 | 0.030 |
Why?
|
| Fetus | 1 | 2021 | 1887 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 1646 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14329 | 0.030 |
Why?
|
| Animals | 6 | 2022 | 167153 | 0.030 |
Why?
|
| Mice | 4 | 2022 | 80750 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2015 | 1338 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1814 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 16795 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2016 | 2617 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 21793 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 1543 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4233 | 0.020 |
Why?
|
| DNA | 1 | 2023 | 7225 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3575 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2023 | 23279 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 21887 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15646 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9484 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6517 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2021 | 18941 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3720 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 5783 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 5418 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8439 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 11898 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 167382 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12491 | 0.010 |
Why?
|
| Female | 2 | 2019 | 387930 | 0.010 |
Why?
|
| Male | 1 | 2015 | 356589 | 0.010 |
Why?
|
| Risk Factors | 1 | 2021 | 73861 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 217991 | 0.000 |
Why?
|